Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Lung Injury – From Pathophysiology to Treatment
Daniela Mokrá
Physiological Research (2021), pp. S353-S366
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

miR-125b-5p in adipose derived stem cells exosome alleviates pulmonary microvascular endothelial cells ferroptosis via Keap1/Nrf2/GPX4 in sepsis lung injury
Kuo Shen, Xujie Wang, Yunwei Wang, et al.
Redox Biology (2023) Vol. 62, pp. 102655-102655
Open Access | Times Cited: 137
Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis
Daniela Mokrá, Marta Jošková, Juraj Mokrý
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 340-340
Open Access | Times Cited: 119
Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications
Xinyu Qiao, Junhao Yin, Zhihuan Zheng, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Polysialic acid-based nanoparticles for enhanced targeting and controlled dexamethasone release in pulmonary inflammation treatment
Cong Li, Jing Li, Yujie Bai, et al.
International Journal of Biological Macromolecules (2025), pp. 139550-139550
Closed Access | Times Cited: 2
Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?
Daniela Mokrá, Jana Adamčáková, Juraj Mokrý
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1566-1566
Open Access | Times Cited: 64
Isoliquiritin apioside relieves intestinal ischemia/reperfusion-induced acute lung injury by blocking Hif-1α-mediated ferroptosis
Zhou Zhongyin, Wei Wang, Juan Xiong, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108852-108852
Closed Access | Times Cited: 42
Construction of a Dual-Functional, Reversible, Ratiometric, Golgi-Targeting Fluorescent Probe for Real-time Monitoring of Dynamics of Intracellular Redox Homeostasis
Shaohui Han, Hong Wang, Haipu Li, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 20, pp. 8002-8010
Closed Access | Times Cited: 25
Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway
Yu-qiong He, Jiuling Deng, Cancan Zhou, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111161-111161
Closed Access | Times Cited: 25
Perillaldehyde ameliorates lipopolysaccharide-induced acute lung injury via suppressing the cGAS/STING signaling pathway
Jiahui Wei, Zhengjia Liu, Hongbin Sun, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111641-111641
Closed Access | Times Cited: 12
Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases
Luyao Shen, Yongsheng Li, Huakan Zhao
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Mechanisms of Sepsis-Induced Acute Lung Injury and Advancements of Natural Small Molecules in Its Treatment
Yaxi Xu, Jianzeng Xin, Yupei Sun, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 472-472
Open Access | Times Cited: 11
Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome
Yitianhe Xu, Leyao Lv, Qian Wang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113869-113869
Closed Access | Times Cited: 10
ANXA3 interference inactivates ERK/ELK1 pathway to mitigate inflammation and apoptosis in sepsis-associated acute lung injury
Jifang Liang, Junkun Zhang, Jixiu Fan, et al.
Molecular Immunology (2024) Vol. 167, pp. 25-33
Closed Access | Times Cited: 9
Regulation of the Nrf2/HO-1 axis by mesenchymal stem cells-derived extracellular vesicles: implications for disease treatment
Hua Su, Zhongan Wang, Lidan Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Inflammation-targeting nanoparticles impede neutrophil infiltration and scavenge ROS for acute lung injury alleviation
Ling Ma, Fang Chen, Shuang Chen, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125359-125359
Closed Access | Times Cited: 1
CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization
Shishuo Sun, Yizhou Yao, Chao Huang, et al.
Cellular Immunology (2022) Vol. 372, pp. 104475-104475
Closed Access | Times Cited: 28
Meteorin-like/Meteorin-β protects LPS-induced acute lung injury by activating SIRT1-P53-SLC7A11 mediated ferroptosis pathway
Zhen Chen, Jun Li, Huan Peng, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Role of toll-like receptors and nod-like receptors in acute lung infection
John Le, Yathushigan Kulatheepan, Samithamby Jeyaseelan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Natural pachypodol integrated, lung targeted and inhaled lipid nanomedicine ameliorates acute lung injury via anti-inflammation and repairing lung barrier
Zhichao Sun, Ran Liao, Caihong Xian, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 300-315
Closed Access | Times Cited: 7
Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice
Wei‐Ting Wang, Yanyu Zhang, Zirui Li, et al.
Phytomedicine (2024) Vol. 129, pp. 155591-155591
Closed Access | Times Cited: 6
Alveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era
Andrea Čalkovská, M Kolomazník, V. Čalkovský
Physiological Research (2021), pp. S195-S208
Open Access | Times Cited: 39
Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines
Wenfang Zhu, Yiwen Zhang, Ying-Hong Wang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization
Xiaohe Li, Yuli Wei, Shimeng Li, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109138-109138
Closed Access | Times Cited: 22
RUNX1 promotes mitophagy and alleviates pulmonary inflammation during acute lung injury
Tang Xiao-ju, Lichun Zhong, Xin Tian, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
Yi Yang, Makhloufi Zoulikha, Qingqing Xiao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4607-4620
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top